UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

Annals of hematology, 2017-11, Vol.96 (11), p.1775-1792

2017

Volltextzugriff (PDF)

Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after Platinum-Containing Therapy: A Multicenter Study of the Arbeitsgemeinschaft Internistische Onkologie

Oncology, 2013-01, Vol.84 (5), p.284-289

2013

Volltextzugriff (PDF)

What is CD4+CD56+ malignancy and how should it be treated?

Bone marrow transplantation (Basingstoke), 2003-10, Vol.32 (7), p.637-646

2003

Volltextzugriff (PDF)

Reduced intensity conditioning allows for up-front allogeneic hematopoietic stem cell transplantation after cytoreductive induction therapy in newly-diagnosed high-risk acute myeloid leukemia

Leukemia, 2006-04, Vol.20 (4), p.707-714

2006

Volltextzugriff (PDF)

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

The New England journal of medicine, 2018-06, Vol.378 (24), p.2288-2301

2018

Volltextzugriff (PDF)

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

The lancet oncology, 2013-05, Vol.14 (6), p.490-499

2013

Volltextzugriff (PDF)

The prognostic impact of 17p ( ) deletion in 2272 adults with acute myeloid leukemia

Leukemia, 2009-04, Vol.23 (4), p.656-663

2009

Volltextzugriff (PDF)

Prevention and treatment of febrile neutropenia

Memo - Magazine of European medical oncology, 2012-04, Vol.5 (1), p.30-34

2012

Volltextzugriff (PDF)

Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial

Leukemia, 2011-03, Vol.25 (3), p.420-428

2011

Volltextzugriff (PDF)

Female patient with a history of Hashimoto's thyroiditis, diagnosed with MALT lymphoma of both breasts

Oncology research and treatment, 2003-06, Vol.26 (3), p.277-280

2003

Volltextzugriff (PDF)

Phase I study of a novel pro-apoptotic drug R-etodolac in patients with B-cell chronic lymphocytic leukemia

Investigational new drugs, 2008-04, Vol.26 (2), p.139-149

2008

Volltextzugriff (PDF)

Biomarkers in chronic graft-versus-host disease: quo vadis?

Bone marrow transplantation (Basingstoke), 2018-07, Vol.53 (7), p.832-837

2018

Volltextzugriff (PDF)

Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT

Leukemia, 2017-10, Vol.31 (10), p.2161-2171

2017

Volltextzugriff (PDF)

NEMO/NF-κB signaling functions as a double-edged sword in PanIN formation versus progression to pancreatic cancer

Molecular cancer, 2024-05, Vol.23 (1), p.103-20, Article 103

2024

Volltextzugriff (PDF)

Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party

Bone marrow transplantation (Basingstoke), 2023-05, Vol.58 (5), p.603-606

2023

Volltextzugriff (PDF)

Potential clinical implications of BRAF mutations in histiocytic proliferations

Oncotarget, 2014-06, Vol.5 (12), p.4060-4070

2014

Volltextzugriff (PDF)

Activation of protein kinase A (PKA) by 8-Cl-cAMP as a novel approach for antileukaemic therapy

British journal of cancer, 2004-07, Vol.91 (1), p.186-192

2004

Volltextzugriff (PDF)

Overexpression of v‐abl uniquely cooperates with c‐myc dysregulation in induction of plasma cell tumors, bypassing the need for T‐lymphocytic help and overcoming T‐lymphocytic interference

International journal of cancer, 1996-07, Vol.67 (1), p.142-147

1996

Volltextzugriff (PDF)

A retrovirus that expresses v-abl and c-myc oncogenes rapidly induces plasmacytomas

Oncogene, 1992-04, Vol.7 (4), p.811-819

1992

Volltextzugriff (PDF)

A raf/myc virus immortalized macrophage cell line which supports the growth of B-cell and B-cell hybridomas

Oncogene, 1990-09, Vol.5 (9), p.1377-1382

1990

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Humans
(16)
Female
(11)
Male
(10)
Middle Aged
(9)
Aged
(8)
Hematology
(8)
Medicine
(8)
Medicine & Public Health
(8)
Adult
(7)
Biological And Medical Sciences
(7)
Patients
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Chemotherapy
(6)
Leukemia
(6)
Medical Sciences
(6)
Medicine/public Health
(6)
Stem Cell Transplantation
(6)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after Platinum-Containing Therapy: A Multicenter Study of the Arbeitsgemeinschaft Internistische Onkologie

What is CD4+CD56+ malignancy and how should it be treated?

Reduced intensity conditioning allows for up-front allogeneic hematopoietic stem cell transplantation after cytoreductive induction therapy in newly-diagnosed high-risk acute myeloid leukemia

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

The prognostic impact of 17p ( ) deletion in 2272 adults with acute myeloid leukemia

Prevention and treatment of febrile neutropenia

Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial

Female patient with a history of Hashimoto's thyroiditis, diagnosed with MALT lymphoma of both breasts

Phase I study of a novel pro-apoptotic drug R-etodolac in patients with B-cell chronic lymphocytic leukemia

Biomarkers in chronic graft-versus-host disease: quo vadis?

Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT

NEMO/NF-κB signaling functions as a double-edged sword in PanIN formation versus progression to pancreatic cancer

Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party

Potential clinical implications of BRAF mutations in histiocytic proliferations

Activation of protein kinase A (PKA) by 8-Cl-cAMP as a novel approach for antileukaemic therapy

Overexpression of v‐abl uniquely cooperates with c‐myc dysregulation in induction of plasma cell tumors, bypassing the need for T‐lymphocytic help and overcoming T‐lymphocytic interference

A retrovirus that expresses v-abl and c-myc oncogenes rapidly induces plasmacytomas

A raf/myc virus immortalized macrophage cell line which supports the growth of B-cell and B-cell hybridomas

Aktive Filter

Suchergebnisse filtern